Bosh sahifa1276 • HKG
add
Jiangsu Hengrui Pharmaceuticals Co Ltd
Yopilish kursi
71,70 $
Kunlik diapazon
72,00 $ - 76,70 $
Yillik diapazon
52,50 $ - 78,80 $
Bozor kapitalizatsiyasi
399,91 mlrd HKD
Oʻrtacha hajm
3,39 mln
Narx/foyda
64,38
Dividend daromadliligi
-
Bozor yangiliklari
Yahoo Finance
18 soat oldin
Stock market today: Dow slips as S&P 500, Nasdaq waver near latest records
0,32%
0,0090%
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (CNY) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 7,21 mlrd | 20,14% |
Joriy xarajat | 4,11 mlrd | 14,94% |
Sof foyda | 1,87 mlrd | 36,90% |
Sof foyda marjasi | 26,01 | 13,98% |
Har bir ulushga tushum | — | — |
EBITDA | 2,21 mlrd | 34,12% |
Amaldagi soliq stavkasi | 9,60% | — |
Balans
Jami aktivlari
Jami passivlari
| (CNY) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 24,20 mlrd | 11,13% |
Jami aktivlari | 51,29 mlrd | 10,69% |
Jami passivlari | 3,74 mlrd | -4,04% |
Umumiy kapital | 47,55 mlrd | — |
Tarqatilgan aksiyalar | 6,25 mlrd | — |
Narxi/balansdagi bahosi | 9,53 | — |
Aktivlardan daromad | 9,99% | — |
Kapitaldan daromad | 10,79% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (CNY) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 1,87 mlrd | 36,90% |
Operatsiyalardan naqd pul | 555,17 mln | -55,75% |
Sarmoyadan naqd pul | -531,68 mln | 29,15% |
Moliyadan naqd pul | -661,06 mln | -3 545,30% |
Naqd pulning sof oʻzgarishi | -607,94 mln | -229,94% |
Boʻsh pul | -1,27 mlrd | -13 096,51% |
Haqida
Jiangsu Hengrui Pharmaceuticals Company Ltd., also known as Jiangsu Hengrui, is a Chinese pharmaceutical company that manufactures and distributes various types of drug packaging materials, cancer-treating antineoplastics, cardiovascular medication, painkillers, antibiotics, and related products. It is the largest listed pharmaceutical company in China. Wikipedia
Tashkil etilgan
1970
Sayt
Xodimlar soni
20 325
